BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 8768744)

  • 21. The effects of d-cycloserine, a partial agonist at the glycine binding site, on spatial learning and working memory in scopolamine-treated rats.
    Pitkänen M; Sirviö J; MacDonald E; Ekonsalo T; Riekkinen P
    J Neural Transm Park Dis Dement Sect; 1995; 9(2-3):133-44. PubMed ID: 8526998
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Posttrial d-cycloserine enhances the emotional memory of an incentive downshift event.
    Norris JN; Ortega LA; Papini MR
    Behav Brain Res; 2011 Oct; 223(2):348-55. PubMed ID: 21596065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of NMDA modulation in scopolamine dementia.
    Jones RW; Wesnes KA; Kirby J
    Ann N Y Acad Sci; 1991; 640():241-4. PubMed ID: 1837979
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mechanism of action of galantamine on N-methyl-D-aspartate receptors in rat cortical neurons.
    Moriguchi S; Marszalec W; Zhao X; Yeh JZ; Narahashi T
    J Pharmacol Exp Ther; 2004 Sep; 310(3):933-42. PubMed ID: 15121761
    [TBL] [Abstract][Full Text] [Related]  

  • 25. D-Cycloserine enhances memory consolidation of hippocampus-dependent latent extinction.
    Gabriele A; Packard MG
    Learn Mem; 2007 Jul; 14(7):468-71. PubMed ID: 17600116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Roles of hippocampal N-methyl-D-aspartate receptors and calcium/calmodulin-dependent protein kinase II in amphetamine-produced conditioned place preference in rats.
    Sakurai S; Yu L; Tan SE
    Behav Pharmacol; 2007 Sep; 18(5-6):497-506. PubMed ID: 17762518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The N-methyl-D-aspartate receptor co-agonist D-cycloserine facilitates declarative learning and hippocampal activity in humans.
    Onur OA; Schlaepfer TE; Kukolja J; Bauer A; Jeung H; Patin A; Otte DM; Shah NJ; Maier W; Kendrick KM; Fink GR; Hurlemann R
    Biol Psychiatry; 2010 Jun; 67(12):1205-11. PubMed ID: 20303474
    [TBL] [Abstract][Full Text] [Related]  

  • 28. N-methyl-D-aspartate receptors in associative eyeblink conditioning: both MK-801 and phencyclidine produce task- and dose-dependent impairments.
    Thompson LT; Disterhoft JF
    J Pharmacol Exp Ther; 1997 May; 281(2):928-40. PubMed ID: 9152403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deficit of NMDA receptor activation in CA1 hippocampal area of aged rats is rescued by D-cycloserine.
    Billard JM; Rouaud E
    Eur J Neurosci; 2007 Apr; 25(8):2260-8. PubMed ID: 17445224
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect on memory processing by D-cycloserine, an agonist of the NMDA/glycine receptor.
    Flood JF; Morley JE; Lanthorn TH
    Eur J Pharmacol; 1992 Oct; 221(2-3):249-54. PubMed ID: 1330624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of ethanol withdrawal on fear memory: Effect of D-cycloserine.
    Bertotto ME; Bustos SG; Molina VA; Martijena ID
    Neuroscience; 2006 Nov; 142(4):979-90. PubMed ID: 16934411
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Responsiveness to brightness change in male and female rats following treatment with the partial agonist of the N-methyl-D-aspartate receptor, D-cycloserine.
    Hughes RN
    Behav Brain Res; 2004 Jul; 152(2):199-207. PubMed ID: 15196787
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Improved cognition in Alzheimer's disease with short-term D-cycloserine treatment.
    Tsai GE; Falk WE; Gunther J; Coyle JT
    Am J Psychiatry; 1999 Mar; 156(3):467-9. PubMed ID: 10080566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential effects of the N-methyl-d-aspartate receptor antagonist MK-801 on different stages of object recognition memory in mice.
    Nilsson M; Hansson S; Carlsson A; Carlsson ML
    Neuroscience; 2007 Oct; 149(1):123-30. PubMed ID: 17826918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A partial agonist at strychnine-insensitive glycine sites facilitates spatial learning in aged rats.
    Popik P; Rygielska Z
    J Physiol Pharmacol; 1999 Mar; 50(1):139-51. PubMed ID: 10210162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy.
    Norberg MM; Krystal JH; Tolin DF
    Biol Psychiatry; 2008 Jun; 63(12):1118-26. PubMed ID: 18313643
    [TBL] [Abstract][Full Text] [Related]  

  • 37. d-Cycloserine: effects on long-term retention of a conditioned response and on memory for contextual attributes.
    Land C; Riccio DC
    Neurobiol Learn Mem; 1999 Nov; 72(3):158-68. PubMed ID: 10536095
    [TBL] [Abstract][Full Text] [Related]  

  • 38. D-cycloserine: a ligand for the N-methyl-D-aspartate coupled glycine receptor has partial agonist characteristics.
    Hood WF; Compton RP; Monahan JB
    Neurosci Lett; 1989 Mar; 98(1):91-5. PubMed ID: 2540460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. d-Cycloserine, a partial agonist at the glycine site, enhances the excitability of dentate granule cells in vivo in rats.
    Pitkänen M; Sirviö J; Lahtinen H; Koivisto E; Riekkinen P
    Eur J Pharmacol; 1994 Feb; 253(1-2):125-9. PubMed ID: 8013538
    [TBL] [Abstract][Full Text] [Related]  

  • 40. D-Serine and a glycine transporter inhibitor improve MK-801-induced cognitive deficits in a novel object recognition test in rats.
    Karasawa J; Hashimoto K; Chaki S
    Behav Brain Res; 2008 Jan; 186(1):78-83. PubMed ID: 17854919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.